Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients
Completed · Not applicable
Conditions studied: Diabetes Mellitus, Type 2, Prediabetic State, Hypertension, Prehypertension, Obesity
In brief
The goal of this study is to explore the effects of FeatForward on physical activity and cardio-metabolic risk factors. The study will be implemented as a 2-arm randomized controlled trial (RCT) comparing the effects of FeatForward in patients assigned to use the application versus a control group who will not use the app over a 6-month follow-up period. The investigators hypothesize that subjects using FeatForward will be more physically active and will achieve greater improvements in their cardio-metabolic risk (CMR) factors than a usual care control group that will not use the app over a 6-month period.
Key facts
- Study ID
- NCT02551640
- Run by
- Massachusetts General Hospital
- People needed
- 300
- Starts
- 2015-09-01
- Expected to finish
- 2019-12-01
- Last updated by the study team
- 2020-09-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years old
- Diagnosis of any of the following: pre-diabetes, Type 2 Diabetes Mellitus (T2DM), pre-hypertension, hypertension, and/or obesity (Body Mass Index (BMI) ≥ 30 kg/m2).
- T2DM: Glycated Hemoglobin (HbA1c) >7.0%
- Hypertension: Blood Pressure (BP) of 140/90 mmHg
- Pre-diabetes: HbA1c >5.7% and BMI ≥ 25 kg/m2
- Pre-hypertension: BP of 130/90 mmHg and family history of high BP
- Willingness to attend all 3 study visits
- Ability to read and speak fluent English
- Physical independence (i.e., ability to walk without assistance)
- Ability to consent for oneself
- Willingness to switch to a provided Samsung smartphone and appropriate phone plan to use as a primary phone for the 6-month study duration
- Willingness to wear a Samsung smartwatch during all hours excluding sleep for the duration of the study
You may not qualify if…
- Participants with severe depression assessed by scoring ≥20 on the PHQ-8 screening questionnaire for depression
- Self-reported eating disorder and/or other psychiatric disorders
- Current or recent participation (within 3 months) in a weight loss program
- Prior or planned bariatric surgery procedure
- Use of medications known to cause significant (≥ 5%) long-term changes in body weight or BP
- Pregnancy or plans to get pregnant within 6 months of enrollment
- Disability, dementia or neurological deficits, and other medical or surgical conditions preventing participants from engaging in self-care
- Serious co-morbid conditions (e.g., terminal cancers, end-stage renal disease) that preclude safe participation in moderate levels of physical activity, under discretion of the participants' primary care provider
Where it is running
- Mass General: Charlestown Healthcare Center — Charlestown, Massachusetts, United States
- Mass General Revere HealthCare Center — Revere, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.